Last reviewed · How we verify
NCT05327764
Work-To-Rest Ratios
NA trial testing Work to rest cycles of 40:20 minutes in Hyperthermia in 15 participants. Completed in 5 November 2023.
5 November 2023
Quick facts
| Lead sponsor | State University of New York at Buffalo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 15 |
| Start date | 21 March 2022 |
| Primary completion | 5 November 2023 |
| Estimated completion | 5 November 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Work to rest cycles of 40:20 minutes
- Work to rest cycles of 20:10 minutes
Conditions studied
- Hyperthermia — all drugs for Hyperthermia →
Sponsor
State University of New York at Buffalo
Who can join
Adults 18 to 39, any sex, with Hyperthermia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to compare physiological responses to two hours of work adhering to two variations of a work-to-rest ratio in a hot environment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05327764
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperthermia
Currently open trials in the same condition.
- NCT07510061 — Title: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient Individuals · NA · recruiting
- NCT06961929 — IEEM-Heat and Heart Failure · NA · recruiting
- NCT06966336 — IEEM- Work:Rest Cycles in Burn Survivors- Humidity · recruiting
- NCT07433036 — The Effectiveness of Emergency Room Protocols for Treating Hyperthermia · NA · recruiting
- NCT06842784 — Impact of Extreme Heat on Myocardial Blood Flow and Flow Reserve in Young and Older Adults · recruiting
Other State University of New York at Buffalo trials
Trials by the same sponsor.
- NCT07072767 — Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation · NA · not yet recruiting
- NCT07140848 — CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes · NA · not yet recruiting
- NCT07433959 — Neuromodulation to Improve Grasping Function After SCI · NA · not yet recruiting
- NCT07403539 — Speech Learning and Speech Production in Parkinson's Disease · NA · recruiting
- NCT05367362 — Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute · Phase 2 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05327764 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by State University of New York at Buffalo
- Last refreshed: 9 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05327764.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing